As of 2024-12-14, the Fair Value of Diagonal Bio AB (DIABIO.ST) is -0.14 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.03 SEK, the upside of Diagonal Bio AB is -666.18%.
Note: valuation result may not be accurate due to the low predictability of business.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | - | 5Y Avg | |
| Net income | -11.66 | -16.16 | -11.68 | - | -13.17 | |
| YoY growth | -1,899.28% | -38.59% | 27.75% | - | -636.71% | |
| Market Cap (mil) | 10.26 |
| P/E | |
| Forward P/E |
| EPS | -0.19 |
| Avg earnings growth rate | -636.71% |
| TTM earnings |